CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Pulsed radiofrequency (RF) facet denervation

Policy governing coverage and medical necessity for pulsed radiofrequency (RF) facet denervation to treat chronic spinal/back pain originating from facet joints for Blue Cross Blue Shield - Rhode Island members.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyPulsed radiofrequency (RF) facet denervation

Policy CodePolicy N/A

Change TypePeriodic review — no material changes

Effective Date02/19/2018

Next Review Date12/17/2025

Key ActionConfirm diagnosis of facet joint pain with diagnostic nerve blocks before considering pulsed radiofrequency denervation.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Not coveredMedicare Advantage coverage stance

Not medically necessaryCommercial products coverage stance

No CPTCoding availability

≤42°CProbe temperature

02/19/2018Policy effective date

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage criteria for pulsed radiofrequency facet denervation

Coverage determination

Coverage stance for pulsed radiofrequency denervation:

Stance: Medicare Advantage Plans: pulsed radiofrequency denervation for the treatment of chronic spinal/back pain is not covered as the evidence is insufficient to determine the effects of the technology on health outcomes.

Stance: Commercial Products: pulsed radiofrequency denervation for the treatment of chronic spinal/back pain is considered not medically necessary as the evidence is insufficient to determine the effects of the technology on health outcomes.

Clinical prerequisites

Clinical expectations described in background and overview:

Diagnostic confirmation: Diagnosis of facet joint pain should be confirmed by a clinically meaningful response to diagnostic medial branch or facet joint nerve blocks before considering pulsed radiofrequency facet denervation.

Pulsed radiofrequency (pulsed RF) and other alternative denervation techniques (for example, alcohol, laser, cryodenervation) are considered not medically necessary because the evidence is insufficient to determine their effects on health outcomes. Pulsed RF delivers short, high-voltage bursts in the radiofrequency range that do not heat tissue sufficiently to cause coagulation (probe tip temperatures do not exceed 42°C), but available data do not demonstrate comparable or durable clinical benefit relative to conventional thermal RF denervation. As such, these alternative denervation methods are not supported for treatment of chronic spinal/back (facet joint) pain under this policy.

For Commercial products, pulsed radiofrequency denervation for treatment of chronic spinal/back pain is considered not medically necessary because the evidence is insufficient to determine the effects of the technology on health outcomes. The policy also notes insufficient evidence to evaluate other alternative denervation methods (eg, alcohol, laser, cryodenervation), and therefore these techniques are likewise considered not medically necessary for Commercial product members.

Coding and device parameters

Unlisted procedure codingCPT

64999

Unlisted procedure, nervous system

inv-06: Probe tip temperature — parameter value

Probe tip temperature≤ 42°C

Comparator (thermal RF) probe temperature~60°C (thermal RF reaches temperatures in the 60°C range)

Clinical implicationTemperatures do not exceed 42°C at the probe tip to avoid coagulation

Provider requirements and billing considerations

Prior Authorization

Prior authorization — verify member-specific requirements

Verify whether prior authorization is required for the member and plan before scheduling pulsed radiofrequency facet denervation. Requirements vary by contract; there is no universal prior authorization rule.

Check member-specific benefits and prior auth rules in the Benefit Booklet, Evidence of Coverage, or Subscriber Agreement.
Medicare Advantage: procedure is not covered (see coverage/medical necessity).

Billing Rule

Coding and benefit documentation — file with unlisted code and verify member benefits

File claims using the unlisted nervous system procedure code and document member benefits and medical necessity in the record. Confirm member coverage limits and plan-specific billing instructions prior to billing.

Background on pulsed radiofrequency therapy

Pulsed RF is used to treat neck and back pain attributed to degenerative changes in facet joints. The technique delivers short bursts of high-voltage electrical current in the radiofrequency range without heating tissue sufficiently to cause coagulation; probe tip temperatures are reported to remain at or below 42°C. It is hypothesized that pulsed RF modulates pain by disrupting transmission in small unmyelinated nerve fibers while sparing large myelinated fibers, but it does not produce the thermal lesion generated by conventional radiofrequency neurotomy. Evidence indicates pulsed RF may be less effective than conventional thermal RF and that long-term benefit is uncertain; nerves can regenerate, potentially necessitating repeat procedures.

Key definitions

inv-12: Pulsed radiofrequency (pulsed RF) definition

DefinitionShort bursts of high-voltage electrical current in the radiofrequency range that do not heat tissue enough to cause coagulation; probe tip temperatures do not exceed approximately 42°C.

MechanismHypothesized to disrupt transmission across small unmyelinated nerve fibers without permanently damaging large myelinated fibers.

Clinical useUsed to treat neck and back pain originating in degenerative facet joints aiming for long-term pain relief (nerves may regenerate requiring repeat procedures).

inv-13: Facet joint pain diagnosis — confirmatory diagnostic blocks

Confirmatory testDiagnosis of facet joint pain should be confirmed by response to diagnostic medial branch or facet joint nerve blocks before considering denervation.

Purpose of confirmation

Confirmatory diagnostic and conservative treatment requirements

Confirmatory diagnostic nerve block response

Confirmatory diagnostic nerve block response — pulsed RF is considered only when facet joint pain is established by diagnostic blocks:

Confirmatory diagnostic nerve block response: A clinically meaningful reduction in pain following diagnostic medial branch or facet joint nerve blocks consistent with the treated pain distribution must be documented prior to performing pulsed radiofrequency denervation.

Imaging and diagnostic procedure requirements

Documentation Required

Document diagnostic nerve block confirmation for facet denervation

As part of imaging/diagnostic requirements for facet denervation, diagnosis must be confirmed by response to diagnostic nerve blocks; document the confirmation in the record.

Ensure diagnostic nerve block response is recorded before scheduling denervation.

Not covered services

Pulsed radiofrequency denervation for chronic spinal/back (facet joint) pain is not covered for Medicare Advantage and is considered not medically necessary for Commercial products. Other alternative denervation techniques (eg, alcohol, laser, cryodenervation) are also considered not medically necessary due to insufficient evidence of benefit. Providers should verify member-specific benefits and billing guidance, as coverage and benefit details may vary by contract.